Cargando…

Multiple system atrophy

This is a practical guide to diagnosing and managing multiple system atrophy (MSA). We explain the newly published Movement Disorders Society Consensus Diagnostic Criteria, which include new ‘Clinically Established MSA’ and ‘Possible Prodromal MSA’ categories, hopefully reducing time to diagnosis. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goh, Yee Yen, Saunders, Emma, Pavey, Samantha, Rushton, Emma, Quinn, Niall, Houlden, Henry, Chelban, Viorica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314081/ https://www.ncbi.nlm.nih.gov/pubmed/36927875 http://dx.doi.org/10.1136/pn-2020-002797

Ejemplares similares

An update on advances in magnetic resonance imaging of multiple system atrophy
por: Chelban, Viorica, et al.
Publicado: (2018)

Analysis of the prion protein gene in multiple system atrophy
por: Chelban, Viorica, et al.
Publicado: (2017)

RFC1-related ataxia is a mimic of early multiple system atrophy
por: Sullivan, Roisin, et al.
Publicado: (2021)

GLS loss of function causes autosomal recessive spastic ataxia and optic atrophy
por: Lynch, David S., et al.
Publicado: (2018)

Multiple system atrophy: genetic risks and alpha-synuclein mutations
por: Whittaker, Heather T, et al.
Publicado: (2017)

A genome-wide association study in multiple system atrophy
por: Sailer, Anna, et al.
Publicado: (2016)

α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy?
por: Kiely, Aoife P., et al.
Publicado: (2013)

An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention
por: Chelban, Viorica, et al.
Publicado: (2020)

Severe axonal neuropathy is a late manifestation of SPG11
por: Manole, Andreea, et al.
Publicado: (2016)

α-Synuclein Strains and Their Relevance to Parkinson’s Disease, Multiple System Atrophy, and Dementia with Lewy Bodies
por: Graves, Noah J., et al.
Publicado: (2023)

Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease
por: Foti, Sandrine C., et al.
Publicado: (2019)

Neurofilament light levels predict clinical progression and death in multiple system atrophy
por: Chelban, Viorica, et al.
Publicado: (2022)

Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients
por: Schottlaender, Lucia V., et al.
Publicado: (2016)

Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment
por: Cortelli, Pietro, et al.
Publicado: (2019)

Truncating mutations in SPAST patients are associated with a high rate of psychiatric comorbidities in hereditary spastic paraplegia
por: Chelban, Viorica, et al.
Publicado: (2017)

Models of multiple system atrophy
por: Lee, He-Jin, et al.
Publicado: (2019)

The genetic basis of multiple system atrophy
por: Tseng, Fan Shuen, et al.
Publicado: (2023)

Heterogeneity of Multiple System Atrophy: An Update
por: Jellinger, Kurt A.
Publicado: (2022)

A novel frameshift deletion in autosomal recessive SBF1-related syndromic neuropathy with necklace fibres
por: Gang, Qiang, et al.
Publicado: (2020)

Animal models of multiple system atrophy
por: Stefanova, Nadia, et al.
Publicado: (2015)

Multiple System Atrophy: Genetic or Epigenetic?
por: Sturm, Edith, et al.
Publicado: (2014)

Tremor in Multiple System Atrophy – a review
por: Kaindlstorfer, Christine, et al.
Publicado: (2013)

Lipid dysfunction and pathogenesis of multiple system atrophy
por: Bleasel, Jonathan M, et al.
Publicado: (2014)

An update on the cerebellar subtype of multiple system atrophy
por: Ciolli, Ludovico, et al.
Publicado: (2014)

Animal modeling an oligodendrogliopathy – multiple system atrophy
por: Bleasel, Jonathan M., et al.
Publicado: (2016)

Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy(1)
por: Jellinger, Kurt A.
Publicado: (2018)

Identification of multiple system atrophy mimicking Parkinson’s disease or progressive supranuclear palsy
por: Miki, Yasuo, et al.
Publicado: (2021)

The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
por: Wenning, Gregor K., et al.
Publicado: (2022)

Multiple System Atrophy: Advances in Diagnosis and Therapy
por: Watanabe, Hirohisa, et al.
Publicado: (2023)

Exploring Myelin Dysfunction in Multiple System Atrophy
por: Wong, Joanna H., et al.
Publicado: (2014)

Role of Oligodendrocyte Lineage Cells in Multiple System Atrophy
por: Hsiao, Jen-Hsiang T., et al.
Publicado: (2023)

Extracellular Interactions of Alpha-Synuclein in Multiple System Atrophy
por: Valdinocci, Dario, et al.
Publicado: (2018)

Multiple system atrophy: clinicopathological characteristics in Japanese patients
por: OZAWA, Tetsutaro, et al.
Publicado: (2017)

Is Multiple System Atrophy a Prion-like Disorder?
por: Jellinger, Kurt A., et al.
Publicado: (2021)

Symptomatic Care in Multiple System Atrophy: State of the Art
por: Grossauer, Anna, et al.
Publicado: (2022)

Inflammation in multiple system atrophy
por: Leńska-Mieciek, Marta, et al.
Publicado: (2023)

Bereitschaftspotential in Multiple System Atrophy
por: Yang, Yi-Chien, et al.
Publicado: (2021)

Cognitive impairment in multiple system atrophy: Changing concepts
por: Abrahão, Agessandro, et al.
Publicado: (2011)

Not to Miss: Intronic Variants, Treatment, and Review of the Phenotypic Spectrum in VPS13D-Related Disorder
por: Pauly, Martje G., et al.
Publicado: (2023)

Multidimensional biomarkers for multiple system atrophy: an update and future directions
por: Wan, Linlin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_05qe6en7opreqc9gm15k8t93jp